2015-2018: The Australian Aplastic Anaemia Registry as a Means for Advancing Effective Treatment of Aplastic Anaemia. Monash University, on behalf of the Aplastic Anaemia Registry (AAR) – an initiative of the Transfusion Outcomes Research Collaborative (a consortium of members of the Monash University Department of Epidemiology and Preventive Medicine at The Alfred Hospital, along with members of the Red Cross Blood Service). The registry received ongoing support in 2018 (see below) and has been re-named The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry. Read more about the project here and for further information, please visit the Registry’s website.
2016-2018 (Grant-in-aid): Identification of miRNA biomarkers which play a functional role in disease pathogenesis and are predictive of inferior outcomes in AA/MDS. Dr Lynette Chee, The Royal Melbourne Hospital/Melbourne Health. Dr Lynette ...Read more
2021-2022 (GIA): Outcomes of Haematopoietic Stem Cell Transplantation for Paediatric Patients with Severe Aplastic Anaemia (SAA) and Bone Marrow Failure (BMF) Syndromes. Dr Steven Keogh, Transplant and Cellular Therapy in Children Group (TACTIC ...Read more
2018-2020 (Grant in aid): Discovering new genes and mutations that cause failure of bone marrow neutrophil production. Professor Graham Lieschke, Australian Regenerative Medicine Institute/Monash University and The Royal Melbourne Hospital. ...Read more
2023- 2025 (Fellowship): Discovery of novel niche factors to improve long-term stem cell transplantation in bone marrow failure syndromes. Dr Vashe Chandrakanthan, The University of Adelaide. For many patients with Bone Marrow Failure Syndromes, ...Read more